Home › Funds › Bleichroeder LP › PROK

Bleichroeder LP position in PROK

PROKIDNEY CORP · Health Care

Bleichroeder LP reported holding 2,000,000 shares of PROK (PROKIDNEY CORP) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.73% of its reported portfolio and ranking #22 among its reported holdings. Bleichroeder LP has disclosed PROK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.00M sh
Reported value held$4.08M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's PROK position evolved

Bleichroeder LP first disclosed a stake in PROK in Q3 2023 at 2,000,000 shares (US$9.2M). Across 12 filings, Bleichroeder LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 2,000,000 shares valued at US$4.1M. Notable position changes include a 31% increase in Q2 2024 (shares fell 22% over the following quarter), a 29% trim in Q3 2024 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.00M $9.16M New
Q4 2023 2.00M $3.56M Hold
Q1 2024 2.00M $3.28M Hold
Q2 2024 2.61M $6.43M Add
Q3 2024 1.84M $3.54M Reduce
Q4 2024 2.00M $3.38M Add
Q1 2025 2.00M $1.75M Hold
Q2 2025 2.00M $1.18M Hold
Q3 2025 2.00M $4.84M Hold
Q4 2025 2.00M $4.48M Hold
Q1 2026 2.00M $3.58M Hold
Q2 2026 2.00M $4.08M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PROK and 13F data

PROK (PROKIDNEY CORP) is a Health Care company. 37 other funds we track also report a position in PROK — the largest reported positions include MONTANOVA CAPITAL, LLC (US$25.2M), Artia Global Partners LP (US$3.7M), Brown University (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PROK

All PROK fund holders →

FAQ

How long has Bleichroeder LP held PROK?

Bleichroeder LP has disclosed PROK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bleichroeder LP's current position in PROK?

As of Q2 2026, Bleichroeder LP holds 2.00M shares of PROK (PROKIDNEY CORP), valued at $4.08M, representing 0.73% of its reported portfolio and ranking #22.

Has Bleichroeder LP been buying or selling PROK?

In the latest 13F filing (Q2 2026), Bleichroeder LP held unchanged its position in PROK.

Which other funds hold PROK?

Other major institutional holders of PROK include MONTANOVA CAPITAL, LLC, Artia Global Partners LP, Brown University, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.